Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EANO guideline on molecular testing of meningiomas for targeted therapy selection.
Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson MD, Kalamarides M, Lamszus K, Albert NL, Mair MJ, Berghoff AS, Mawrin C, Wirsching HG, Maas SL, Raleigh DR, Reifenberger G, Schweizer L, Suwala AK, Tabatabai G, Tabouret E, Short S, Wen PY, Weller M, Le Rhun E, Wesseling P, van den Bent M, Preusser M. Sahm F, et al. Among authors: mair mj. Neuro Oncol. 2024 Nov 22:noae253. doi: 10.1093/neuonc/noae253. Online ahead of print. Neuro Oncol. 2024. PMID: 39577862
Implication of surgical loupes on complications following thyroidectomy: a meta-analysis.
Rao KN, Zafereo M, Rao AN, Nixon I, Robbins KT, Sreeram MP, Rodrigo JP, Sanabria A, Mair M, Vander Poorten V, Guntinas-Lichius O, Ronen O, Kowalski LP, Randolph G, Ferlito A. Rao KN, et al. Among authors: mair m. Eur Arch Otorhinolaryngol. 2024 Oct 7. doi: 10.1007/s00405-024-09003-2. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 39375200 Review.
Translating the theranostic concept to neuro-oncology: disrupting barriers.
Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N, Jakola AS, Niyazi M, Smits M, Verger A, Cicone F, Weller M, Preusser M; European Organisation for Research and Treatment of Cancer Brain Tumor Group. Albert NL, et al. Among authors: mair mj. Lancet Oncol. 2024 Sep;25(9):e441-e451. doi: 10.1016/S1470-2045(24)00145-1. Lancet Oncol. 2024. PMID: 39214115 Review.
Misconducts in research and methods to uphold research integrity.
Rao KN, Mair M, Arora RD, Dange P, Nagarkar NM. Rao KN, et al. Among authors: mair m. Indian J Cancer. 2024 Apr 1;61(2):354-359. doi: 10.4103/ijc.ijc_4_23. Epub 2024 Jul 16. Indian J Cancer. 2024. PMID: 39016268 Free article.
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases.
Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Mair MJ, Starzer AM, Forstner H, Rottenmanner B, Aretin MB, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Pfeiler G, Singer C, Weltermann A, Berchtold L, Preusser M. Bartsch R, et al. Among authors: mair mj. Neuro Oncol. 2024 Dec 5;26(12):2305-2315. doi: 10.1093/neuonc/noae123. Neuro Oncol. 2024. PMID: 38963808 Free PMC article. Clinical Trial.
193 results